First step for potential delirium treatment begins human testing
NCT ID NCT07422142
Summary
This is a very early study to check if a new injection called Gastrodin is safe for people and to see how the body handles it. It will involve 54 healthy volunteers in China. The main goal is to watch for any side effects and measure how the drug moves through and leaves the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELIRIUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Tianjin, Tianjin Municipality, China
Conditions
Explore the condition pages connected to this study.